George Farmer
Stock Analyst at Scotiabank
(2.14)
# 2,928
Out of 5,006 analysts
71
Total ratings
46.15%
Success rate
-3.96%
Average return
Main Sectors:
Top Industries:
Stocks Rated by George Farmer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMEA Biomea Fusion | Maintains: Sector Outperform | $30 → $10 | $2.67 | +274.53% | 4 | Aug 6, 2025 | |
| ACLX Arcellx | Maintains: Sector Outperform | $93 → $133 | $84.58 | +57.25% | 4 | Jul 31, 2025 | |
| INMB INmune Bio | Downgrades: Sector Underperform | $23 → $0.6 | $2.06 | -70.87% | 3 | Jul 1, 2025 | |
| URGN UroGen Pharma | Maintains: Sector Outperform | $23 → $47 | $17.05 | +175.66% | 1 | Jun 13, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Sector Perform | $16 → $17 | $16.41 | +3.60% | 4 | May 6, 2025 | |
| TARA Protara Therapeutics | Initiates: Sector Outperform | $12 | $4.87 | +146.41% | 1 | Apr 16, 2025 | |
| TPST Tempest Therapeutics | Downgrades: Sector Perform | $91 → $9 | $10.87 | -17.20% | 4 | Apr 10, 2025 | |
| ADAP Adaptimmune Therapeutics | Maintains: Sector Outperform | $3.15 → $1.4 | $0.13 | +947.12% | 2 | Mar 21, 2025 | |
| JANX Janux Therapeutics | Maintains: Sector Perform | $62 → $41 | $22.76 | +80.14% | 4 | Feb 28, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Sector Outperform | $47 → $52 | $32.51 | +59.95% | 4 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $78 → $80 | $55.61 | +43.86% | 8 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $244 → $224 | $154.05 | +45.41% | 3 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $102 | $32.28 | +215.99% | 1 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $18 → $10 | $9.80 | +2.04% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Sector Outperform | $439 → $715 | $787.94 | -9.26% | 5 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $20 → $23 | $5.92 | +288.51% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $20 | $1.90 | +952.63% | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $70 → $76 | $31.44 | +141.73% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $3.76 | +245.74% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $109 | $27.54 | +295.79% | 3 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $94 → $87 | $87.23 | -0.26% | 5 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $2.28 | +1,347.37% | 1 | Oct 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $0.94 | +4,155.32% | 1 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $27 | $39.99 | -32.48% | 3 | May 6, 2020 |
Biomea Fusion
Aug 6, 2025
Maintains: Sector Outperform
Price Target: $30 → $10
Current: $2.67
Upside: +274.53%
Arcellx
Jul 31, 2025
Maintains: Sector Outperform
Price Target: $93 → $133
Current: $84.58
Upside: +57.25%
INmune Bio
Jul 1, 2025
Downgrades: Sector Underperform
Price Target: $23 → $0.6
Current: $2.06
Upside: -70.87%
UroGen Pharma
Jun 13, 2025
Maintains: Sector Outperform
Price Target: $23 → $47
Current: $17.05
Upside: +175.66%
Syndax Pharmaceuticals
May 6, 2025
Maintains: Sector Perform
Price Target: $16 → $17
Current: $16.41
Upside: +3.60%
Protara Therapeutics
Apr 16, 2025
Initiates: Sector Outperform
Price Target: $12
Current: $4.87
Upside: +146.41%
Tempest Therapeutics
Apr 10, 2025
Downgrades: Sector Perform
Price Target: $91 → $9
Current: $10.87
Upside: -17.20%
Adaptimmune Therapeutics
Mar 21, 2025
Maintains: Sector Outperform
Price Target: $3.15 → $1.4
Current: $0.13
Upside: +947.12%
Janux Therapeutics
Feb 28, 2025
Maintains: Sector Perform
Price Target: $62 → $41
Current: $22.76
Upside: +80.14%
NewAmsterdam Pharma Company
Feb 27, 2025
Maintains: Sector Outperform
Price Target: $47 → $52
Current: $32.51
Upside: +59.95%
Feb 20, 2025
Maintains: Sector Perform
Price Target: $78 → $80
Current: $55.61
Upside: +43.86%
Feb 13, 2025
Maintains: Sector Outperform
Price Target: $244 → $224
Current: $154.05
Upside: +45.41%
Feb 13, 2025
Initiates: Sector Outperform
Price Target: $102
Current: $32.28
Upside: +215.99%
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $10
Current: $9.80
Upside: +2.04%
Nov 5, 2024
Upgrades: Sector Outperform
Price Target: $439 → $715
Current: $787.94
Upside: -9.26%
Oct 18, 2024
Maintains: Sector Outperform
Price Target: $20 → $23
Current: $5.92
Upside: +288.51%
Sep 30, 2024
Initiates: Sector Outperform
Price Target: $20
Current: $1.90
Upside: +952.63%
Aug 12, 2024
Maintains: Sector Outperform
Price Target: $70 → $76
Current: $31.44
Upside: +141.73%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $3.76
Upside: +245.74%
Nov 17, 2020
Downgrades: Market Perform
Price Target: $109
Current: $27.54
Upside: +295.79%
Nov 6, 2020
Maintains: Market Perform
Price Target: $94 → $87
Current: $87.23
Upside: -0.26%
Oct 27, 2020
Initiates: Outperform
Price Target: $33
Current: $2.28
Upside: +1,347.37%
Jul 20, 2020
Initiates: Outperform
Price Target: $40
Current: $0.94
Upside: +4,155.32%
May 6, 2020
Maintains: Market Perform
Price Target: $20 → $27
Current: $39.99
Upside: -32.48%